When you are investing millions in developing a new drug, finding hidden costs before they become real problems is mission critical. FERVOR offers a systematic approach integrating advanced data, therapeutic expertise and real-world experience that can substantially improve planning, feasibility and enrollment targets. Sources includes
KOL opinion
FERVOR’s medical writing support for the full life cycle of a product’s development, beginning with early-stage development through marketing application and post-approval.
Clinical Research data
No matter what therapeutic area or disease indication you’re developing for, you can tap into our extensive experience and get your pharmaceutical drug or medical de-vice to the people who need it.
Public source data
Fervoriers knows how to meet milestone in a agreed budget and support the clients to bring new therapies in a faster possible way
Industry benchmark
Healthcare decisions are increasingly based on evidence and value. Fervoriers use evidence derived from HEOR and RWE to drive market access and improve patient out-comes
This approach allows you to develop or optimize a protocol design to deliver the right data from the start, without unexpected issues or unnecessary costs.
Control costs and avoid potential roadblocks
Whether you are in the process of developing or have already developed your trial protocol, FERVOR can support you in testing it using real world data to check for precision, clarity and consistency, including:
Feasibility for patient and site burden to identify barriers to patient recruitment and retention Identifying non-core procedures so you can remove them to reduce study costs and complexity
Understanding competitors to benchmark design and enrollment strategies and maximize study value
Improving eligibility criteria to help recruit eligible patients and predict screen failure